Bruker touts multiomics platform at HUPO Reconnect 2021

By The Science Advisory Board staff writers

November 16, 2021 -- Bruker touted advances in collision cross section-enabled 4D proteomics workflows on the trapped ion mobility spectrometry time-of-flight (timsTOF) multiomics platform at the Human Proteome Organization World Congress, HUPO Reconnect 2021.

The company announced it has reached a co-marketing agreement with Cellenion on the cellenONE single-cell isolation and nanoliter dispensing robotic platform. The partnership provides timsTOF SCP users with an end-to-end solution, the company said.

The cellenONE single-cell isolation and nanoliter dispensing robotic platform.
The cellenONE single-cell isolation and nanoliter dispensing robotic platform. Image courtesy of Bruker.

Bruker also highlighted its collaboration with Seer on its Proteograph product suite, saying the combination of Proteograph with timsTOF platforms allows researchers to dig deeper into the plasma proteome.

Finally, the company presented results on its expanded partnership with Preomics on its novel BeatBox technology for tissue proteomics. The combined workflow resulted in coverage of more than 4,000 protein IDs for mouse lung and 2,300 protein IDs for mouse heart muscle.

Bruker's Q2 earnings show recovery from COVID-19
Bruker's second-quarter earnings report illustrates recovery from the COVID-19 pandemic, with a 34% increase in revenue compared to the same period in...
Bruker launches new tools to improve 4D-metabolomics, lipidomics workflows
Bruker has launched several products to enhance the accuracy of 4D-metabolomics and lipidomics workflows, including a new ion source for its trapped ion...
Bruker expands timsTOF product line
Bruker has added two new instruments to its trapped ion mobility spectrometry time-of-flight (timsTOF) product suite, including the second-generation...
Bruker launches FT-NMR benchtop spectrometer
Bruker has unveiled its permanent-magnet Fourier 80 system, an 80-MHz Fourier transform nuclear magnetic resonance (FT-NMR) benchtop spectrometer for...
Bruker invests in Acuity's in situ spatial genomics platform
Acuity Spatial Genomics has announced the completion of a majority investment by Bruker.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter